• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

Rivian stock soars over 24% after Q4 deliveries exceeds expectations

by January 3, 2025
written by January 3, 2025

Investing.com — Shares of Rivian (NASDAQ:RIVN) surged over 24% on Friday, marking its best day since November 2021, as the company exceeded expectations for fourth-quarter deliveries, announcing that a component shortage no longer limits its production.

This marks a significant step forward for the electric vehicle maker as it works toward profitability.

The shortage, which affected parts used in its R1 SUV, R1T pickup trucks, and delivery vans, emerged in the third quarter and led the company to reduce its annual production target in October.

“The previously discussed shortage of a shared component on the R1 and RCV platforms is no longer a constraint on Rivian’s production,” the company said in a statement.

Rivian delivered 14,183 vehicles during the three months ending Dec. 31, surpassing the 13,472 vehicles projected by 15 analysts surveyed by Visible Alpha.

This represented a 42% increase from the previous quarter and was Rivian’s highest quarterly delivery total in over a year, even though Amazon (NASDAQ:AMZN), its largest investor, typically scales back deliveries in the fourth quarter to prioritize holiday operations.

The company produced 12,727 vehicles in the fourth quarter, exceeding analysts’ estimates of 11,398 units.

For the full year, Rivian manufactured 49,476 vehicles—down about 13% from 2023 but slightly above the revised forecast of 47,000 to 49,000 units.

“With the supplier/component concern in the rearview mirror, the focus will now be on RIVN’s ability to execute on its path toward profitability as we see only modest YoY growth in FY25 ahead of the company’s planned 2026 R2 launch at Normal,” Truist Securities analysts said in a note.

“We’d expect shares to react positively to the print, although we’ll be largely looking ahead to the company’s earnings release in February as we await FY25 guidance/mgmt commentary.”

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
Goldman Sachs names Alex Golten as chief risk officer
next post
Brazil stocks lower at close of trade; Bovespa down 1.43%

You may also like

BASF results down on impairments, restructuring

January 27, 2025

European chipmakers slump as traders gauge DeepSeek AI...

January 27, 2025

Nasdaq futures tumble as China’s AI push rattles...

January 27, 2025

China Vanke’s CEO, chairman resign amid growing liquidity...

January 27, 2025

Fuji Media, rocked by sexual misconduct allegations, says...

January 27, 2025

Italy’s MPS shares fall ahead of Mediobanca board...

January 27, 2025

British Land stock drops following stake sale

January 27, 2025

UMG shares rally after new multi-year pact with...

January 27, 2025

BASF shares indicated 3% lower as impairments drag...

January 27, 2025

Ryanair cuts 2026 traffic forecast amid ongoing Boeing...

January 27, 2025
Fill Out & Get More Relevant News








    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent Posts

    • Netflix says its ad tier now has 94 million monthly active users

      May 15, 2025
    • Dick’s Sporting Goods to buy struggling Foot Locker for $2.4 billion

      May 15, 2025
    • YouTube will stream NFL Week 1 game in Brazil for free

      May 15, 2025
    • 5 new Uber features you should know — including a way to avoid surge pricing

      May 15, 2025

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (463)
    • Stock (6,426)

    Latest News

    • Netflix says its ad tier now has 94 million monthly active users
    • Dick’s Sporting Goods to buy struggling Foot Locker for $2.4 billion

    Popular News

    • Australia’s Premier eyes worst session in nearly 5 years on bleak retail outlook
    • Scholar Rock stock surges on positive spinal muscular atrophy treatment data

    About The Significant deals

    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy